Impact of a Single Intracoronary Administration of Adiponectin on Myocardial Ischemia/Reperfusion Injury in a Pig Model
Authors:
- 1 April 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Interventions
- Vol. 3 (2) , 166-173
Abstract
Background— Adiponectin plays a protective role in the development of obesity-linked disorders. We demonstrated that adiponectin exerts beneficial actions on acute ischemic injury in mice hearts. However, the effects of adiponectin treatment in large animals and its feasibility in clinical practice have not been investigated. This study investigated the effects of intracoronary administration of adiponectin on myocardial ischemia-reperfusion (I/R) injury in pigs. Methods and Results— The left anterior descending coronary artery was occluded in pigs for 45 minutes and then reperfused for 24 hours. Recombinant adiponectin protein was given as a bolus intracoronary injection during ischemia. Cardiac functional parameters were measured by a manometer-tipped catheter. Apoptosis was evaluated by terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling staining. Tumor necrosis factor-α and interleukin-10 transcripts were analyzed by real-time polymerase chain reaction. Serum levels of derivatives of reactive oxygen metabolites and biological antioxidant potential were measured. Adiponectin protein was determined by immunohistochemical and Western blot analyses. Intracoronary administration of adiponectin protein led to a reduction in myocardial infarct size and improvement of left ventricular function in pigs after I/R. Injected adiponectin protein accumulated in the I/R-injured heart. Adiponectin treatment resulted in decreased tumor necrosis factor-α and increased interleukin-10 mRNA levels in the myocardium after I/R. Adiponectin-treated pigs had reduced apoptotic activity in the I/R-injured heart and showed increased biological antioxidant potential levels and decreased derivatives of reactive oxygen metabolite levels in the blood stream after I/R. Conclusions— These data suggest that adiponectin protects against I/R injury in a preclinical pig model through its ability to suppress inflammation, apoptosis, and oxidative stress. Administration of intracoronary adiponectin could be a useful adjunctive therapy for acute myocardial infarction.Keywords
This publication has 44 references indexed in Scilit:
- Adiponectin-mediated modulation of hypertrophic signals in the heartNature Medicine, 2004
- Inhibition of δ-Protein Kinase C Protects Against Reperfusion Injury of the Ischemic Heart In VivoCirculation, 2003
- The Metabolic SyndromeCirculation, 2003
- Cloning of adiponectin receptors that mediate antidiabetic metabolic effectsNature, 2003
- The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarctionHeart, 2003
- Diet-induced insulin resistance in mice lacking adiponectin/ACRP30Nature Medicine, 2002
- Fundamentals of Reperfusion Injury for the Clinical CardiologistCirculation, 2002
- The inflammatory response in myocardial infarctionCardiovascular Research, 2002
- Cardiac ResuscitationNew England Journal of Medicine, 2001
- An Adipocyte-Derived Plasma Protein, Adiponectin, Adheres to Injured Vascular WallsHormone and Metabolic Research, 2000